Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ganglioneuroblastoma × Irinotecan × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 66 Colonic Neoplasms 28 Rectal Neoplasms 27 Neoplasm Metastasis 14 Stomach Neoplasms 10 Pancreatic Neoplasms 9 Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Small Cell Lung Carcinoma 5 Rhabdomyosarcoma 4 Intestinal Neoplasms 4 Gastrointestinal Neoplasms 4 Digestive System Neoplasms 4 Uterine Cervical Neoplasms 3 Sarcoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Cholangiocarcinoma 3 Rectal Diseases 2 Neoplasms by Histologic Type 2 Intestinal Diseases 2 Hepatoblastoma 2 Gastrointestinal Diseases 2 Digestive System Diseases 2 Colorectal Cancer Metastatic 2 Colorectal Adenocarcinoma 2 Colonic Diseases 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

dinutuximab 2 Magnetic Resonance Spectroscopy 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 Biopsy 2 sargramostim 1 lorlatinib 1 etoposide phosphate 1 Watchful Waiting 1 Vincristine 1 Topotecan 1 Thiotepa 1 Temozolomide 1 Stem Cell Transplantation 1 Specimen Handling 1 Razoxane 1 Radiation 1 Platinum 1 Observation 1 Melphalan 1 Isotretinoin 1 Irinotecan 1 High-Energy Shock Waves 1 Etoposide 1 Dexrazoxane 1 Congresses as Topic 1 Colony-Stimulating Factors 1 Cisplatin 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07375563 2026-01-29

NB-NK-2026

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡